Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Asthma medication plays a key role in how well you control your condition. There are two main types of treatment, each geared toward a specific goal. Controller medications are the most important ...

While yoga is essentially a physical act, it is more about the science of enlivening the body, mind, and breath in perfect ...